Elias Nicolas Kiwan, M.D.
Investigator
Dr. Elias Nicolas Kiwan is a board‑certified hematologist and oncologist with extensive expertise in blood cancers and bone marrow transplantation. He serves as Director of the Blood and Marrow Transplant Program at Sutter Medical Group, where he has practiced since 2011. Trained at the Lebanese University Faculty of Medicine and the University of Arkansas for Medical Sciences, Dr. Kiwan previously held an academic appointment at the Myeloma Institute for Research and Therapy. He has authored numerous publications in hematologic malignancies, infectious complications in cancer, and stem‑cell transplantation. Fluent in Arabic, English, and French, he remains dedicated to advancing patient care, research, and clinical outcomes in hematology and oncology.
Research studies
- Research study
Bone Marrow Transplant Database
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Clinical trials
- Clinical trial
Lymphoma, Large B-Cell, Diffuse Expanded Access For Subjects Receiving Lisocabtagen Maraleucel JCAR017-EAP-001
Expanded Access Protocol (EAP) For Subjects Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release (JCAR017-EAP-001)
Status: Open to Enrollment
- Clinical trial
Multiple Myeloma Expanded Access to Ciltacabtagene Autoleucel (Cilta-Cel) 68284528MMY4006
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-cel) Out-of-Specification (OOS) in Patients With Multiple Myeloma
Status: Open to Enrollment
Expanded Access Protocol (EAP) for Patients Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release
Status: Coming Soon